Back to results
US 2026/0258044 A1Published application
Piperidinyl-methyl-purine amine fumaric acid salts, crystalline forms, and their use in treating medical diseases and conditions
AssigneesK36 Therapeutics, Inc., Novartis AG
InventorsTerrence Joseph Connolly, Chad Arthur Lewis, Erika Dianne Butler, Tengfei Li, Xuan Dai
Life of this patent
Estimating the term…
Abstract
The invention provides piperidinyl-methyl-purine amine fumaric acid salts, crystalline forms, pharmaceutical compositions, their use in inhibiting NSD2, and their use in the treatment of a disease or condition, such as cancer.
Claims61
A compound that is a fumaric acid salt of the following compound:
Dependencies are inferred from the claim text.